EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

EBR Systems Inc (EBR) fair value: what the stock is really worth

We calculate from audited financials what EBR Systems Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Sep 13, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · AU · ISIN AU0000182552

ES Thin data Sep 13, 2026

EBR Systems Inc

EBR · AU

SpeculativeUpside exists, but weak quality makes the signal speculative.

✓Fair value A$0.3400 · Undervalued (+21.4%)
!Quality 13/100
!Weak Growth
!High debt · negative free cash flow
!Trails peers (2/9)
!Narrow moat 6/100
!Evidence only low, so the estimate is less certain
!Weak on balance sheet: 20 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

A$2.01 A$0.2400 Fair Value A$0.3400 Nov 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

58‑month range A$0.2400 – A$2.01 · fair‑value band A$0.2465 – A$0.4250 · the A$0.2800 price screens below the A$0.3400 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.

Follow EBR Systems in your weekly email

Every Wednesday you see whether EBR Systems is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation.

Show more

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

Stock analysis

EBR Systems Inc (EBR) currently trades at A$0.2800, while our model-based Fair Value estimate is A$0.3400, implying the stock looks roughly 17.6% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 3 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: A$0.2465 (bear) to A$0.4250 (bull), the price of A$0.2800 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 13/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

EBR Systems Inc reported revenue of $1.7M in FY2025 versus $0 in FY2020. Reported net income was −$50.5M in FY2025.

Key figures

Market cap A$211M (≈ $147M) · P/E ratio 1.6 · P/S ratio 67.2 · EPS (TTM) A$0.1700 · Return on equity −459% · Return on assets (EBIT) −35.8% · Operating margin −685% · Revenue (TTM) $4.0M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 81% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at 21%, EBR screens cheaper than that median.

Fair Value models

Bear A$0.2465 Fair Value A$0.3400 Bull A$0.4250
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (A$0.1276 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) A$0.0200 A$0.0300 A$0.0500 52
All 1 models by family
Asset-Based
NCAV (Graham) A$0.0200 A$0.0300 A$0.0500 52

Open the full fair value analysis →

Notify me when EBR reaches fair value

Put EBR on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 13/100

Of which business quality 16 · Market factors (momentum, volatility) 16

Profitability 0
Margins and returns on capital today
Quality Growth 29
Are margins and returns improving?
Cashflow 13
Earnings quality: real cash, not paper profit
Fin. Strength 17
Balance sheet, leverage, solvency risk
Investment 49
Disciplined investing over empire-building
Low Volatility 48
Calm price path (market factor)
Momentum 2
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch EBR, get fair value alerts →

Compare EBR Systems Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 354 stocks

Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 13 · Bottom 25%
Fair Value upside +21.4% · Top 25%
Profitability
Return on assets −42.1% · Bottom 25%
Growth and dividend
Revenue growth 0.0% · Below median
Balance sheet
Debt / equity 1.60× · Highest 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/E (TTM) 1.6× · Cheapest 25%
P/B 5.72× · Priciest 25%
P/S (TTM) 36.82× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)62 · sector 4
FUTURE (revenue growth)0 · sector 31
PAST (return on equity)0 · sector 8
HEALTH (low debt)20 · sector 97
DIVIDEND (yield)0 · sector 38

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $101.29 $74.79 −26%
Medtronic plc MDT $87.09 $65.61 −25%
Stryker Corporation SYK $278.77 $306.65 +10%
Boston Scientific Corporation BSX $43.92 $48.31 +10%
Edwards Lifesciences Corporation EW $86.29 $81.94 −5%
Siemens Healthineers AG SHL €37.79 €35.19 −7%
DexCom, Inc DXCM $86.68 $95.35 +10%
GE HealthCare Technologies Inc GEHC $66.63 $70.37 +6%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥153.86 ¥169.25 +10%
Koninklijke Philips N.V PHIA €21.87 €15.23 −30%

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "EBR Systems Inc Fair Value". https://www.fairvalue-calculator.com/stock/EBR

Frequently asked questions

Is EBR Systems Inc (EBR) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of A$0.3400 versus a price of A$0.2800, about +21% upside (undervalued).
What is the fair value of EBR?
Our model-based fair value for EBR Systems Inc is A$0.3400 (as of Sep 13, 2026), built from audited fundamentals. The current price: A$0.2800.
What is the quality score of EBR?
EBR Systems Inc has a Quality Score of 13/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for EBR Systems Inc (EBR)?
Our model-based price target is the fair value of A$0.3400 (as of Sep 13, 2026) from 1 valuation models. Cautious scenario A$0.2465, optimistic scenario A$0.4250. It is a calculation from audited fundamentals, not an analyst target.
What is the EBR Systems Inc stock forecast for 2026?
Our models put fair value at A$0.3400, about +21% upside versus a price of A$0.2800 (undervalued). Cautious scenario A$0.2465, optimistic scenario A$0.4250. The calculation is refreshed regularly with new filings.
What is the revenue of EBR Systems Inc (EBR)?
EBR Systems Inc reported trailing-twelve-month revenue of about $4.0M (latest available figure, as of Sep 13, 2026).
What is the intrinsic value of EBR Systems Inc (EBR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For EBR Systems Inc it is A$0.3400 per share (as of Sep 13, 2026), against a price of A$0.2800. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is EBR Systems Inc stock overvalued or undervalued in 2026?
As of Sep 13, 2026, EBR trades below its calculated fair value: price A$0.2800, fair value A$0.3400, a gap of about +21% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of EBR?
No. The price is what the market pays today (A$0.2800); the fair value is what the company's own numbers justify (A$0.3400). For EBR Systems Inc the two are A$0.0600 per share apart. That gap is exactly why we show both numbers side by side.
How much is EBR Systems Inc worth?
The market values EBR Systems Inc at about A$211M (market capitalisation, as of Sep 13, 2026). Per share that is A$0.2800; our models calculate a fair value of A$0.3400 per share.
What do the bullish and bearish scenarios say about EBR?
Our models span a range for EBR Systems Inc: cautious scenario A$0.2465, base A$0.3400, optimistic A$0.4250 per share (as of Sep 13, 2026, price A$0.2800). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of EBR?
EBR Systems Inc trades at a price-to-earnings ratio of 1.6 (as of Sep 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of A$0.3400 is built from several models across several years. Other multiples: P/B 5.7, P/S 36.8.
How solid is the balance sheet of EBR Systems Inc (EBR)?
Balance-sheet figures for EBR Systems Inc (as of Sep 13, 2026): return on equity −458.8%, debt of 1.60 per unit of equity. They feed the Quality Score of 13/100, which measures business quality independently of the share price.
How far is EBR from its 52-week high?
EBR Systems Inc trades at A$0.2800, about 81% below its 52-week high of A$1.47 and 17% above the low of A$0.2400 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.3400 is for.
Which stocks are comparable to EBR Systems Inc?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is EBR Systems Inc stock attractive at the current price?
The data as of Sep 13, 2026: price A$0.2800, calculated fair value A$0.3400 (+21%), Quality Score 13/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of EBR calculated?
We run EBR Systems Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of A$0.3400, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.7 % above its aggregate fair value. EBR Systems Inc currently trades 18 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of EBR Systems Inc (EBR)?
The closing price on Sep 30, 2026 was A$0.2800. Our model-based fair value is A$0.3400, about +21% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with EBR Systems Inc right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of EBR Systems Inc

How large is the market capitalisation of EBR Systems Inc (EBR)?
The market capitalisation of EBR Systems Inc is A$211M (≈ $147M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of EBR Systems Inc (EBR)?
The price-to-sales ratio of EBR Systems Inc is 67.2 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of EBR Systems Inc (EBR)?
Earnings per share at EBR Systems Inc are A$0.1700 (price ÷ EPS = P/E 1.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of EBR Systems Inc (EBR)?
The return on equity (ROE) of EBR Systems Inc is −459% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of EBR Systems Inc (EBR)?
On an EBIT basis the return on assets of EBR Systems Inc is −35.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of EBR Systems Inc (EBR)?
The operating margin of EBR Systems Inc is −685% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does EBR Systems Inc (EBR) generate?
The free cash flow of EBR Systems Inc is −$58.9M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does EBR Systems Inc (EBR) carry?
The net debt of EBR Systems Inc is $52.8M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch EBR Systems Inc in the live analysis

One click puts EBR Systems Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.